However, early APC mutations are acquired in over 80% of colon cancer patients, leading to the cytosolic accumulation of β-catenin, an intracellular signal transducer in transcriptional regulation that, in combination with TCF/Lef1, promotes proliferation and inhibits apoptosis [21]. The gene discussed is APC; the disease is malignant colon neoplasm.